Contact
Please use this form to send email to PR contact of this press release:
Hepion Pharmaceuticals, Inc. Granted 180-day Extension by Nasdaq to Meet the Minimum Bid Price Requirements
TO:
Please use this form to send email to PR contact of this press release:
Hepion Pharmaceuticals, Inc. Granted 180-day Extension by Nasdaq to Meet the Minimum Bid Price Requirements
TO: